This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Estrogen receptor
From Proteopedia
| Line 27: | Line 27: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *Estrogen receptor α ligand binding domain | + | *Estrogen receptor α ligand binding domain residues 245-554 |
**[[4n1y]] - ERα LBD – pacific oyster<br /> | **[[4n1y]] - ERα LBD – pacific oyster<br /> | ||
| Line 36: | Line 36: | ||
**[[1err]], [[3ert]], [[1sj0]], [[1yim]], [[1r5k]], [[1xp1]], [[1xp6]], [[1xp9]], [[1xpc]], [[1xqc]], [[1yin]], [[2ouz]], [[2iog]], [[2iok]], [[3dt3]], [[3os8]], [[3os9]], [[3osa]], [[5t92]], [[5t97]] - hERα LBD + ligand<br /> | **[[1err]], [[3ert]], [[1sj0]], [[1yim]], [[1r5k]], [[1xp1]], [[1xp6]], [[1xp9]], [[1xpc]], [[1xqc]], [[1yin]], [[2ouz]], [[2iog]], [[2iok]], [[3dt3]], [[3os8]], [[3os9]], [[3osa]], [[5t92]], [[5t97]] - hERα LBD + ligand<br /> | ||
**[[4xi3]] - hERα LBD + bazedoxifene<br /> | **[[4xi3]] - hERα LBD + bazedoxifene<br /> | ||
| - | **[[2bj4]], [[2jf9]], [[2jfa]], [[1pcg]] - hERα LBD + peptide antagonist<br /> | + | **[[2bj4]], [[2jf9]], [[2jfa]], [[1pcg]], [[5gtr]], [[5gs4]] - hERα LBD + peptide antagonist<br /> |
**[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | **[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | ||
| + | **[[6cbz]] - hERα LBD (mutant) + GRIP peptide + estradiol<br /> | ||
**[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | **[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | ||
**[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | **[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | ||
**[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | **[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | ||
| - | **[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]], [[5aau]], [[5aav]], [[5acc]], [[5ak2]], [[5di7]], [[5did]], [[5die]], [[5dig]], [[5dk9]], [[5dkb]], [[5dke]], [[5dkg]], [[5dks]], [[5dl4]], [[5dlr]], [[5dmc]], [[5dmf]], [[5dp0]] - hERα LBD (mutant) + antagonist<br /> | + | **[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]], [[5aau]], [[5aav]], [[5acc]], [[5ak2]], [[5di7]], [[5did]], [[5die]], [[5dig]], [[5dk9]], [[5dkb]], [[5dke]], [[5dkg]], [[5dks]], [[5dl4]], [[5dlr]], [[5dmc]], [[5dmf]], [[5dp0]], [[6chz]], [[6chw]], [[6c42]], [[6b0f]], [[5w9d]], [[5ufx]], [[5ufw]] - hERα LBD (mutant) + antagonist<br /> |
| + | **[[4q50]] - hERα LBD (mutant) + tamoxifen derivative<br /> | ||
**[[3uuc]] - hERα LBD + bisphenol<br /> | **[[3uuc]] - hERα LBD + bisphenol<br /> | ||
**[[5t1z]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | **[[5t1z]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | ||
**[[1gwr]] - hERα LBD + TIF2 peptide + EST<br /> | **[[1gwr]] - hERα LBD + TIF2 peptide + EST<br /> | ||
**[[2ocf]] - hERα LBD (mutant) + fibronectin domain 10 + EST<br /> | **[[2ocf]] - hERα LBD (mutant) + fibronectin domain 10 + EST<br /> | ||
| + | **[[2yja]] - hERα LBD + NCAO2 peptide<br /> | ||
| + | **[[2b23]] - hERα LBD (mutant) + NCAO2 peptide<br /> | ||
*''ERα LBD ternary complex with nuclear receptor coactivator 2 peptide (NCAO2)'' | *''ERα LBD ternary complex with nuclear receptor coactivator 2 peptide (NCAO2)'' | ||
**[[2yja]] - hERα LBD + NCAO2 peptide<br /> | **[[2yja]] - hERα LBD + NCAO2 peptide<br /> | ||
| - | **[[5hyr]], [[5dx3]], [[5dxb]], [[4pxm]] - hERα LBD (mutant) + NCAO2 peptide + estradiol<br /> | + | **[[5hyr]], [[5dx3]], [[5dxb]], [[4pxm]], [[3q95]] - hERα LBD (mutant) + NCAO2 peptide + estradiol<br /> |
**[[5dxb]] - hERα LBD (mutant) + NCAO2 peptide + stilbestrol derivative<br /> | **[[5dxb]] - hERα LBD (mutant) + NCAO2 peptide + stilbestrol derivative<br /> | ||
**[[4zn7]] - hERα LBD + NCAO2 peptide + benzylidene estrone<br /> | **[[4zn7]] - hERα LBD + NCAO2 peptide + benzylidene estrone<br /> | ||
**[[5kri]], [[5krj]], [[5krk]], [[5krl]], [[5krm]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | **[[5kri]], [[5krj]], [[5krk]], [[5krl]], [[5krm]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | ||
**[[5egv]], [[ehj]], [[5ei1]], [[5eit]], [[5dxk]], [[5dxe]], [[5dxg]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | **[[5egv]], [[ehj]], [[5ei1]], [[5eit]], [[5dxk]], [[5dxe]], [[5dxg]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | ||
| - | **[[5dxe]], [[5dxg]], [[5dxk]], [[5dxm]], [[5dxp]], [[5dxq]], [[5dxr]], [[5dy8]], [[5dyb]], [[5dyd]], [[5dz0]], [[5dz1]], [[5dz3]], [[5dzh]], [[5dzi]], [[5e0w]], [[5e0x]], [[5e14]], [[5e15]], [[5e19]], [[5e1c]], [[5drj]], [[5drm]], [[5dtv]], [[5du5]], [[5due]], [[5dug]], [[5duh]], [[5dvs]], [[5dvv]], [[5dwe]], [[5dwg]], [[5dwi]], [[5dwj]] - hERα LBD (mutant) + NCAO2 peptide + antagonist<br /> | + | **[[5dxe]], [[5dxg]], [[5dxk]], [[5dxm]], [[5dxp]], [[5dxq]], [[5dxr]], [[5dy8]], [[5dyb]], [[5dyd]], [[5dz0]], [[5dz1]], [[5dz3]], [[5dzh]], [[5dzi]], [[5e0w]], [[5e0x]], [[5e14]], [[5e15]], [[5e19]], [[5e1c]], [[5drj]], [[5drm]], [[5dtv]], [[5du5]], [[5due]], [[5dug]], [[5duh]], [[5dvs]], [[5dvv]], [[5dwe]], [[5dwg]], [[5dwi]], [[5dwj]], [[4iu7]], [[4iui]], [[4iv2]], [[4iv4]], [[4ivw]], [[4ivy]], [[4iw6]], [[4iw8]], [[4iwc]], [[4iwf]], [[5u2d]], [[5tld]], [[5tlf]], [[5tlg]], [[5tll]], [[5tlm]], [[5tlo]], [[5tlp]], [[5tlt]], [[5tlu]], [[5tlv]], [[5tlx]], [[5tly]], [[5tm1]], [[5tm2]], [[5tm3]], [[5tm4]], [[5tm5]], [[5tm6]], [[5tm7]], [[5tm8]], [[5tm9]], [[5tml]], [[5tmo]], [[5tmm]], [[5tmq]], [[5tmr]], [[5tms]], [[5tmt]], [[5tmu]], [[5tmv]], [[5tmw]], [[5tmz]], [[5tn1]], [[5tn3]], [[5tn4]], [[5tn5]], [[5tn6]], [[5tn7]], [[5tn8]], [[5ehj]] - hERα LBD (mutant) + NCAO2 peptide + antagonist<br /> |
| - | **[[5kcf]], [[5kct]], [[5kcu]], [[5kcw]], [[5kd9]], [[5kcc]], [[5kcd]], [[4zn9]], [[4znh]], [[4zns]], [[4znt]], [[4znu]], [[4znv]], [[4znw]] - hERα LBD (mutant) + NCAO2 peptide + OBHS derivative<br /> | + | **[[5kcf]], [[5kct]], [[5kcu]], [[5kcw]], [[5kd9]], [[5kcc]], [[5kcd]], [[5kce]], [[4zn9]], [[4znh]], [[4zns]], [[4znt]], [[4znu]], [[4znv]], [[4znw]] - hERα LBD (mutant) + NCAO2 peptide + OBHS derivative<br /> |
**[[5kr9]] - hERα LBD (mutant) + NCAO2 peptide + coumestrol<br /> | **[[5kr9]] - hERα LBD (mutant) + NCAO2 peptide + coumestrol<br /> | ||
| + | **[[2g5o]] - hERα LBD + NCAO2 peptide + EST derivative<br /> | ||
| + | **[[2qgt]], [[5krh]], [[5krc]], [[5kra]] - hERα LBD (mutant) + NCAO2 peptide + EST derivative<br /> | ||
| + | **[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + NCAO2 peptide + ligand<br /> | ||
| + | **[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + NCAO2 peptide + ligand<br /> | ||
| + | **[[2qa8]] - hERα LBD (mutant) + NCAO2 peptide + genistein<br /> | ||
| + | **[[4pp6]], [[4ppp]], [[4pps]] - hERα LBD (mutant) + NCAO2 peptide + resveratrol derivative<br /> | ||
*''ERα LBD ternary complex with steroid receptor coactivator 1 peptide'' | *''ERα LBD ternary complex with steroid receptor coactivator 1 peptide'' | ||
| - | **[[3uu7]], [[3uua]], [[3uud]] - hERα LBD (mutant) + | + | **[[3uu7]], [[3uua]], [[3uud]] - hERα LBD (mutant) + NCAO1 peptide<br /> |
| - | **[[4dma]] - hERα LBD (mutant) + | + | **[[4dma]] - hERα LBD (mutant) + NCAO1 peptide + inhibitor<br /> |
| - | **[[4mg5]], [[4mg6]], [[4mg7]], [[4mg8]], [[4mg9]], [[4mga]], [[4mgb]], [[4mgc]], [[4mgd]] - hERα LBD (mutant) + | + | **[[4mg5]], [[4mg6]], [[4mg7]], [[4mg8]], [[4mg9]], [[4mga]], [[4mgb]], [[4mgc]], [[4mgd]] - hERα LBD (mutant) + NCAO1 peptide + ligand<br /> |
| - | **[[4tuz]] - hERα LBD (mutant) + | + | **[[4tuz]] - hERα LBD (mutant) + NCAO1 peptide + toxin<br /> |
| - | **[[4tv1]] - hERα LBD (mutant) + | + | **[[4tv1]] - hERα LBD (mutant) + NCAO1 peptide + preservative<br /> |
| + | **[[5jmm]] - hERα LBD (mutant) + NCAO1 peptide + biochanin<br /> | ||
*''ERα LBD ternary complex with steroid receptor coactivator 2 peptide'' | *''ERα LBD ternary complex with steroid receptor coactivator 2 peptide'' | ||
| - | **[[2b23]] - hERα LBD (mutant) + | + | **[[2b23]] - hERα LBD (mutant) + NCAO2 peptide<br /> |
| - | **[[3q95]] - hERα LBD (mutant) + | + | **[[3q95]] - hERα LBD (mutant) + NCAO2 peptide + EST<br /> |
| - | **[[4iu7]], [[4iui]], [[4iv2]], [[4iv4]], [[4ivw]], [[4ivy]], [[4iw6]], [[4iw8]], [[4iwc]], [[4iwf]], [[5u2d]], [[5tld]], [[5tlf]], [[5tlg]], [[5tll]], [[5tlm]], [[5tlo]], [[5tlp]], [[5tlt]], [[5tlu]], [[5tlv]], [[5tlx]], [[5tly]], [[5tm1]], [[5tm2]], [[5tm3]], [[5tm4]], [[5tm5]], [[5tm6]], [[5tm7]], [[5tm8]], [[5tm9]], [[5tml]], [[5tmo]], [[5tmm]], [[5tmq]], [[5tmr]], [[5tms]], [[5tmt]], [[5tmu]], [[5tmv]], [[5tmw]], [[5tmz]], [[5tn1]], [[5tn3]], [[5tn4]], [[5tn5]], [[5tn6]], [[5tn7]], [[5tn8]] - hERα LBD (mutant) + | + | **[[4iu7]], [[4iui]], [[4iv2]], [[4iv4]], [[4ivw]], [[4ivy]], [[4iw6]], [[4iw8]], [[4iwc]], [[4iwf]], [[5u2d]], [[5tld]], [[5tlf]], [[5tlg]], [[5tll]], [[5tlm]], [[5tlo]], [[5tlp]], [[5tlt]], [[5tlu]], [[5tlv]], [[5tlx]], [[5tly]], [[5tm1]], [[5tm2]], [[5tm3]], [[5tm4]], [[5tm5]], [[5tm6]], [[5tm7]], [[5tm8]], [[5tm9]], [[5tml]], [[5tmo]], [[5tmm]], [[5tmq]], [[5tmr]], [[5tms]], [[5tmt]], [[5tmu]], [[5tmv]], [[5tmw]], [[5tmz]], [[5tn1]], [[5tn3]], [[5tn4]], [[5tn5]], [[5tn6]], [[5tn7]], [[5tn8]] - hERα LBD (mutant) + NCAO2 peptide + inhibitor<br /> |
| - | **[[2g5o]] - hERα LBD + | + | **[[2g5o]] - hERα LBD + NCAO2 peptide + EST derivative<br /> |
| - | **[[2qgt]] - hERα LBD (mutant) + | + | **[[2qgt]] - hERα LBD (mutant) + NCAO2 peptide + EST derivative<br /> |
| - | **[[5kce]] - hERα LBD (mutant) + | + | **[[5kce]] - hERα LBD (mutant) + NCAO2 peptide + OBHS derivative<br /> |
| - | **[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + | + | **[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + NCAO2 peptide + ligand<br /> |
| - | **[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + | + | **[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + NCAO2 peptide + ligand<br /> |
| - | **[[2qa8]] - hERα LBD (mutant) + | + | **[[2qa8]] - hERα LBD (mutant) + NCAO2 peptide + genistein<br /> |
| - | **[[4pp6]], [[4ppp]], [[4pps]] - hERα LBD (mutant) + | + | **[[4pp6]], [[4ppp]], [[4pps]] - hERα LBD (mutant) + NCAO2 + resveratrol derivative<br /> |
*''ERα LBD ternary complex with steroid receptor coactivator 3 peptide'' | *''ERα LBD ternary complex with steroid receptor coactivator 3 peptide'' | ||
| - | **[[1x7r]] - hERα LBD + | + | **[[1x7r]] - hERα LBD + NCAO3 peptide + genistein<br /> |
| - | **[[1x7e]] - hERα LBD + | + | **[[1x7e]] - hERα LBD + NCAO3 peptide + ligand<br /> |
*Estrogen receptor β ligand binding domain | *Estrogen receptor β ligand binding domain | ||
| Line 89: | Line 100: | ||
**[[1qkm]] - hERβ LBD + genistein<br /> | **[[1qkm]] - hERβ LBD + genistein<br /> | ||
**[[1qkn]], [[1hj1]] - ERβ LBD + ligand – rat<br /> | **[[1qkn]], [[1hj1]] - ERβ LBD + ligand – rat<br /> | ||
| - | **[[1nde]], [[1u3q]], [[1u3r]], [[1u3s]], [[2giu]], [[2i0g]], [[2i0j]], [[2jj3]], [[2z4b]], [[2qtu]] - hERβ LBD + ligand<br /> | + | **[[1nde]], [[1u3q]], [[1u3r]], [[1u3s]], [[2giu]], [[2i0g]], [[2i0j]], [[2jj3]], [[2z4b]], [[2qtu]], [[5toa]] - hERβ LBD + ligand<br /> |
**[[2yly]] - hERβ LBD + sulfonamide agonist<br /> | **[[2yly]] - hERβ LBD + sulfonamide agonist<br /> | ||
**[[2fsz]] - hERβ LBD (mutant) + ligand<br /> | **[[2fsz]] - hERβ LBD (mutant) + ligand<br /> | ||
| Line 98: | Line 109: | ||
*''ERβ LBD ternary complex with steroid receptor coactivator peptide'' | *''ERβ LBD ternary complex with steroid receptor coactivator peptide'' | ||
| - | **[[1l2j]] - hERβ LBD + | + | **[[1l2j]] - hERβ LBD + NCAO peptide + nonsteroidal EST<BR /> |
| - | **[[2j7x]], [[3oll]], [[3ols]] - hERβ LBD + | + | **[[2j7x]], [[3oll]], [[3ols]] - hERβ LBD + NCAO peptide + EST<BR /> |
| - | **[[1u9e]] - hERβ LBD + | + | **[[1u9e]] - hERβ LBD + NCAO peptide<br /> |
| - | **[[1x76]], [[1x78]], [[1x7b]], [[1yy4]], [[1yye]], [[1zaf]], [[2j7y]], [[2nv7]], [[3omo]], [[3omp]], [[3omq]] - hERβ LBD + | + | **[[1x76]], [[1x78]], [[1x7b]], [[1yy4]], [[1yye]], [[1zaf]], [[2j7y]], [[2nv7]], [[3omo]], [[3omp]], [[3omq]] - hERβ LBD + NCAO peptide + ligand<br /> |
| - | **[[1x7j]] - hERβ LBD + | + | **[[1x7j]] - hERβ LBD + NCAO peptide + genistein |
| - | *Estrogen receptor α DNA binding domain | + | *Estrogen receptor α DNA binding domain residues 182-252 |
**[[1hcp]] – hERα DBD – NMR<br /> | **[[1hcp]] – hERα DBD – NMR<br /> | ||
Revision as of 07:17, 22 May 2018
| |||||||||||
For more details see
Ivan Koutsopatriy estrogen receptor
C-di-GMP receptors with PilZ domain
For more details on ERβ see Student Project 10 for UMass Chemistry 423 Spring 2015
For more details on ER-Tamoxifen complex see Tamoxifen.
3D structures of estrogen receptor
Updated on 22-May-2018
Reference
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y

